CPC C07K 14/45 (2013.01) [A23L 33/195 (2016.08); A23L 33/40 (2016.08); A61P 31/04 (2018.01); A61P 37/06 (2018.01); A23V 2002/00 (2013.01); A61K 38/00 (2013.01)] | 6 Claims |
1. A method for treating an inflammatory disease, the method comprising a step of administering to an individual a composition including Toxoplasma gondii GRA9 protein as an active ingredient.
|